CE vs INSM · rev $10.28B vs rev $363.7M
Celanese Corporation (CE) versus Insmed Inc (INSM) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Insmed Inc (INSM) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported INSM revenue for 2024-12-31 was $363.7M. Net income was -$913.8M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. INSM currently screens at market cap $20.42B.
CE currently screens at market cap $5.92B. INSM currently screens at market cap $20.42B.
Not investment advice. Open the CE and INSM stock pages for the full models.
Not investment advice.